HGHaris Gul

Haris Gul

*This is an algorithmically generated author record based on publicly available information.

Haris Gul has a total of 9 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Anti-Ro Positivity in Systemic Lupus Erythematosus: Association with Clinical Phenotypes and Serological Profile

    by Anum Khan, Shahida Perveen, Haris Gul, Babur Salim, Saba Samreen, Umme Laila Hashmi

    Objective: To determine the association of anti-Ro antibody with the clinical features and serology in systemic lupus erythematosus (SLE) patients. Methods: This retrospective observational study enrolled 158 SLE patients at the Rheumatology Department, Fauji Foundation Hospital, from May 1 to October 31, 2023. Demographic and clinical data were collected. Patients were stratified by anti-Ro (positive vs. negative), concomitant anti-La (anti-Ro[ ]/anti-La[ ], anti-Ro[ ]/anti-La[ ], anti-Ro[ ]/anti-La[ ], and anti-Ro[ ]/anti-La[ ]), and anti-nuclear antibody (ANA) status (positive vs. negative). Mann-Whitney U and Chi-square tests were employed for comparisons, with statistical significance set at p<0.05. Results: The study population consisted mainly of females (98.7%), with a median age of 30 years. Anti-Ro[ ] patients (46.8%) exhibited higher discoid rash (16.2% vs. 6%, p [ ] 0.04), sicca symptoms (52.7% vs. 31%, p [ ] 0.005), and anemia (71.6% vs. 56%, p [ ] 0.04). No significant differences were observed in nephritis (29.7% vs. 34.5%, p [ ] 0.52) or neurological disease (9.5% vs. 11.9%, p [ ] 0.69) between the two groups. The anti-Ro[ ]/anti-La[ ] group had higher myositis (20.6%), sicca symptoms (55.9%), and fever (70.6%) compared to other groups. The ANA[ ]/anti-Ro[ ] group (48.6%) had significant association with sicca symptoms (50.7%) and fever (64.2%). Conclusion: Anti-Ro[ ] SLE in South Asians is associated with sicca symptoms, anemia, fever, and myositis—findings critical for tailored management. Co-positivity with anti-La amplifies risks, warranting vigilant monitoring.

  • Open Access

    Abstract 13 — Comparison of Clinical and Serological Features in Juvenile and Adult-Onset Systemic Lupus Erythematosus

    by Babur Salim, Anum Khan, Haris Gul, Saba Samreen, Shahida Perveen

    Background Systemic lupus erythematosus (SLE) has varying clinical and serological features in juvenile and adult-onset disease groups, depending on the ethnicity. Objectives: To compare the disease characteristics of patients with adult-onset (ASLE) and juvenile-onset systemic lupus erythematosus (JSLE). Methods It is a cross-sectional study, carried out at Rheumatology department Fauji Foundation Hospital. 184 SLE patients were included. They were divided into adult (n=152) and juvenile (n=32) group. The clinical and serological features at the time of disease onset were compared between the two groups. Statistical analysis was done using chi square and t-test. Results The mean age was 36.22 ± 11.48 in adults and 19.94 ± 7.17 in the juvenile group (t = 7.71, p<0.001). The duration of disease was 46.05 ± 45.74 months(adult) and 62.43 ± 84.00 months (juvenile). There was no significant difference in disease activity, SLE disease activity index (SLEDAI) was 13 in adult lupus patients and 14.5 in the juvenile, t-value=1.1 and p-value=0.39. Sicca symptoms were significant in the ASLE (p=0.004). Neuropsychiatric manifestations (p=0.03), thrombocytopenia (p=0.048) and low complement levels (0.02) were significantly higher in JSLE. Serological profiles did not differ significantly in the two groups. Conclusion The features of SLE differ in adult and juvenile patients. Neurological involvement and thrombocytopenia were more prevalent in JSLE, whereas sicca symptoms were more frequently found in ASLE.

  • Open Access

    Translation and validation of MHAQ score in local language Urdu in Patients with rheumatoid arthritis presenting in a tertiary care center of Pakistan

    by Amna Ehsan, Samina Mushtaq, Babur Salim, Saba Samreen, Haris Gul, Amjad Nasim

    Objective: To translate and validate the Modified Health Assessment Questionnaire from English to Urdu. Method: The validation study was conducted at the Rheumatology outpatient department of Fauji Foundation Hospital, Rawalpindi, Pakistan, from July 1 to September 30, 2019. Two translators were given the modified health assessment questionnaire for translation from English to Urdu. It was then back-translated by two independent translators. The translated version of the tool was applied to rheumatoid arthritis patients to check for reliability, test-retest and internal consistency. It was applied to another group of patients to check for criterion validity. Reliability analysis was checked by applying Cronbach alpha. Criterion validity was checked by assessing disease activity score-28 and its correlation with Modified Health Assessment Questionnaire. Data was analysed using SPSS 23. Results: Of the 30 patients in the initial testing, 28(93%) were females and 2(6.6%) were males, with an overall mean age of 38±13.2 years. Of the 100 patients in the second group, 97(97%) were women and 3(3%) were men, with an overall mean age of 42±12.37 years. The mean disease duration of the cohort was 8.4±4.8 years. The Cronbach alpha value was 0.797 and interclass coefficient was 0.7, reflecting good reliability. A significantly high correlation between Modified Health Assessment Questionnaire and disease activity score-28 was noted along with pain, tenderness, swollen joints, patient global assessment, age and erythrocyte sedimentation rate (p0.05). ---Continue